LYVE-1 immunocytochemical staining for gastrointestinal carcinoids

References

• Banerji S, Ni J, Wang S W, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789–801
   PubMed Web of Science ®Google Scholar
• Jackson D G, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trend Immunol 2001; 22: 317–321
   PubMed Web of Science ®Google Scholar
• Prevo R, Banaerji S, Ferguson J P, Clasper S, Jackson D G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001; 276: 19420–19430
   PubMed Web of Science ®Google Scholar
• Jackson D G. The lymphatics revisited. New perspectives from the hyaluronan receptor LYVE-1. Trend Cardiovasc Med 2003; 13: 1–7
   PubMed Web of Science ®Google Scholar
• Stacker S A, Baldwin M E, Acher M G. The role of tumor lymphangiogenesis in metastatic spread. FASEB 2002; 16: 922–934
   PubMed Web of Science ®Google Scholar
• Carrreira C M, Nasser S M, di Tonaso E, et al. LYVE-1 is not restricted to the lymphatic vessel. Cancer Res 2001; 61: 8079–8084
   PubMed Web of Science ®Google Scholar
• Tomita T. LYVE-1 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors. Pancreas 2007; 35: e18–e22
   PubMedGoogle Scholar
• Sipos B, Klapper W, Kruse M L, Kaltoff H, Kaejaschki D, Kloppel G. Expression of lymphangiogenetic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol 2004; 165: 1187–1197
   PubMed Web of Science ®Google Scholar
• Tomita T. Immunocytochemical localization of prohormone convertase 1/3 and 2 in gastrointestinal carcinoids. Endocr Pathol 2001; 12: 137–145
   PubMed Web of Science ®Google Scholar
• LYVE-1. In: R&D Systems. 2006 Catalog. R&D Systems, Mineapolis 2006; 564
   Google Scholar
• Creuzfeldt W. Carcinoid tumors: development of our knowledge. World J Surg 1996; 20: 126–131
   PubMed Web of Science ®Google Scholar
• Kloppel G, Heitz P U, Capella C, Solcia E. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg 1996; 20: 132–141
   PubMed Web of Science ®Google Scholar
• Larsson A, Alwmark A, Nobin Sundler F. Endocrine tumors of the duodenum: clinical characteristics and hormone content. Ann Surg 1983; 197: 393–398
   PubMed Web of Science ®Google Scholar
• Capella C, Riva C, Rindi G, et al. Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: a study of 44 cases. Endocr Pathol 1991; 2: 92–110
   PubMedGoogle Scholar
• Koura A N, Giacco C, Curley S A, Skibber J M, Feig B W, Ellis L M. Carcinoid tumors of the rectum. Cancer 1997; 79: 1294–1298
   PubMed Web of Science ®Google Scholar
• Dayal Y. Neuroendocrine cells of gastrointestinal tract: introduction and historical prospective. Endocrine Pathology of the Gut and Pancreas, Y Dayal, O P Ganda. CRC, Boca Raton, FL 1991; 1–31
   Google Scholar
• Jain R K, Fenton B T. Intratumoral lymphatic vessels: A case of mistaken identity or malfunction. J Natl Cancer Inst 2002; 94: 417–421
   PubMedGoogle Scholar
• Koukourakis M I, Giatromanolaki A, Sirridis E. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005; 58: 202–206
   PubMed Web of Science ®Google Scholar
• Tomita T. Immunocytochemical localization of lymphatic and venous vessels in colonic polyps and adenomas. Dig Dis Sci 2007; 53: 1880–1885
   PubMed Web of Science ®Google Scholar
• Bailey D, Baumal R, Law J, Shelidan K, Kahn H J. Production of monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 1986; 83: 5291–5295
   PubMed Web of Science ®Google Scholar
• Kahn H J, Marks A. A new monoclonal antibody D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002; 82: 1255–1257
   PubMed Web of Science ®Google Scholar
• Urabe A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K. Grading system of lymphatic invasion according to D2–40 immunostaining is useful for the prediction of nodal metastases in squamous cell carcinoma of the uterine cervix. Histopathology 2006; 49: 493–497
   PubMed Web of Science ®Google Scholar
• Tomita T. D2–40 immunostaining for pancreatic islets and pancreatic endocrine tumors. Pancreas, (in press)
   Google Scholar